Intradermal Delivery ofShigellaIpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes-Reference-Cited by-同舟云学术

Intradermal Delivery ofShigellaIpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes

Published:2014-01-22 Issue:4 Volume:192 Page:1630-1640
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Heine Shannon J.,Diaz-McNair Jovita,Andar Abhay U.,Drachenberg Cinthia B.,van de Verg Lillian,Walker Richard,Picking Wendy L.,Pasetti Marcela F.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Enteric infections and the vaccines to counter them: Future directions

5. Progress and pitfalls in Shigella vaccine research

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate;npj Vaccines;2024-01-02

2. Refining Immunogenicity through Intradermal Delivery of Outer Membrane Vesicles against Shigella flexneri in Mice;International Journal of Molecular Sciences;2023-11-29

3. A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice;Infection and Immunity;2023-11-16

4. AAV-Mediated Targeting of the Activin A-ACVR1R206H Signaling in Fibrodysplasia Ossificans Progressiva;Biomolecules;2023-09-08

5. Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.;Frontiers in Immunology;2023-09-06